Toxicity assessment of acute lymphoblastic leukemia treatment protocol ALL IC-BFM 2002
Background. Treatment results of acute lymphoblastic leukemia in children on protocol, developed by one of the leading research study group BFM (Berlin-Frankfurt-Munster) are impressive - longstanding overall survival rate comprise 93.4 %. The basis of success is a differential approach based on pro...
Saved in:
| Main Authors: | T. T. Valiev, M. A. Shervashidze, T. S. Belysheva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/568 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Native and pegylated forms of L-asparaginase: the assessment of effectiveness and toxicity in acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster (BFM) protocol
by: M. A. Shervashidze, et al.
Published: (2024-12-01) -
The role of high-dose methotrexate in T-cell acute lymphoblastic leukemia treatment: multicenter study results of ALL IC-BFM 2002 protocol
by: T. T. Valiev, et al.
Published: (2024-12-01) -
Treatment of Pediatric Acute Lymphoblastic Leukemia in India as per modified BFM 95 protocol with Minimal Residual Disease monitoring
by: Dhwanee Thakkar, et al.
Published: (2025-12-01) -
Neurocognitive and neuroanatomical changes in children with acute lymphoblastic leukemia treated with the modified BFM-95 protocol
by: Sundaramoorthy Chidambaram, et al.
Published: (2019-01-01) -
Comparative analysis of three various chemotherapy protocols for acute lymphoblastic leukemia BFM-90m, MB-91 and PECO-92 in Moscow and St.-Petersburg
by: E. G. Boichenko, et al.
Published: (2022-11-01)